Lightlake Therapeutics Announces Phase II Clinical Trial Results of Treatment …

Published April 5, 2013

Lightlake Therapeutics Announces Phase II Clinical Trial Results of Treatment …
Intranasal naloxone is absorbed within minutes, and over time, results in the extinction of the harmful eating behavior. Naloxone exerts its effects over two hours, which is the typical duration of a binge, and is unlikely to extinguish other healthy … Read more on MarketWatch (press release)

C. Everett Koop, 1916–2013
A former pipe smoker, he said cigarettes were as addictive as heroin and cocaine…. Koop, a devout Presbyterian, was confirmed after he told a Senate panel he would not use the surgeon …. Then a discussion by Dr. Koop of fetal development, then a … Read more on The Nation. (blog)